Basecamp Wealth Advisors’s RAPT Therapeutics RAPT Stock Holding History

Basecamp Wealth Advisors’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-68	Closed	-$2.3K	–	2135
2025 Q4	$2.3K	Buy	+68	New	+$2.11K	﹤0.01%	1321

Basecamp Wealth Advisors's RAPT Position: Q1 2026 in Review

Basecamp Wealth Advisors sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 68 shares — an estimated $2.3K sold.

Basecamp Wealth Advisors first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $2.3K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Basecamp Wealth Advisors reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Basecamp Wealth Advisors sold 68 RAPT Therapeutics shares in Q1 2026, an estimated $2.3K.
Basecamp Wealth Advisors first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
Basecamp Wealth Advisors's RAPT Therapeutics position peaked at $2.3K in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q1 2026, filed 24 Jun 2026.